First Solana STO Backs a Dentist's Needle, Not a Meme 🦷
First Block, Inc., Onpharma Company (Delaware) and UK-based Crito Capital LLP announced on June 17th, 2026 the launch of what the parties describe as the first Security Token Offering built on Solana for an established U.S. operating business, with the offering hosted at sto.onpharma.com. The transaction deploys Solana blockchain infrastructure, combining atomic settlement technology, programmable ownership architecture, and digital distribution capabilities, structured within existing U.S. securities law. A Security Token Offering represents and transfers ownership rights in a company's common stock via blockchain-based digital tokens rather than traditional share registers. The Onpharma issuance is structured as a Regulation S offshore placement to non-U.S. investors and is designed to deliver issuance, settlement, and cross-border distribution to qualified investors at lower cost and faster speed than conventional private-market channels. Secondary transactions are intended to occur on-chain across compatible wallets subject to KYC controls, with near-instantaneous settlement and international accessibility under Regulation S and other applicable frameworks. Onpharma manufactures the Onset EZ local anaesthetic buffering product used to buffer millions of dental injections annually, and its disposable Onset EZ Pen requires no assembly or specialist training, integrating directly into existing dental workflows. The company is positioned at a post-validation, pre-scale stage, with infrastructure, supply chain, regulatory compliance, and initial commercialisation already complete. Septodont's February 2025 market entry is cited by the partners as validation that anaesthetic buffering is becoming an emerging standard of care, and the recurring consumable revenue from the Onset EZ Pen is presented as the underlying economic logic for the tokenised raise.
Share Article
Quick Info
Disclaimer: This content is for information and entertainment purposes only. It does not constitute financial, investment, legal, or tax advice. Always do your own research and consult with qualified professionals before making any financial decisions.
See our Terms of Service, Privacy Policy, and Editorial Policy.